SEED Therapeutics

China Clears IND for SEED Therapeutics’ First-in-Class Cancer Drug in Global Trial Push

KING OF PRUSSIA, PA — SEED Therapeutics announced that China’s National Medical Products Administration has cleared the Investigational New Drug application for ST-01156, enabling Chinese sites to participate in the …

China Clears IND for SEED Therapeutics’ First-in-Class Cancer Drug in Global Trial Push Read More

Madrigal Pharmaceuticals

Breakthrough Liver Drug Shows Powerful Two-Year Gains — But Raises a Critical Warning

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) unveiled new two-year data showing that its flagship therapy Rezdiffra produced sustained improvements in patients with compensated MASH cirrhosis, a population with …

Breakthrough Liver Drug Shows Powerful Two-Year Gains — But Raises a Critical Warning Read More

Cencora

Cencora’s Earnings Surprise? Pharma Distributor Posts Big Gains—and a Rare Quarterly Loss

CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) reported a mixed finish to fiscal 2025, delivering strong full-year performance despite a significant fourth-quarter GAAP loss driven by impairment and integration charges. …

Cencora’s Earnings Surprise? Pharma Distributor Posts Big Gains—and a Rare Quarterly Loss Read More